New Lenox Park District Board Approves 2025-2026 Budget
NEW LENOX – The New Lenox Community Park District Board of Commissioners unanimously approved the budget and appropriation ordinance for the 2025-2026 fiscal year during its regular meeting on June 18.
The passage of Ordinance #25-05-01 marks the culmination of the district’s annual budget process. The vote followed a formal public hearing held at 6:00 p.m., just prior to the board’s regular session at the Village Hall. No members of the public offered comments during the hearing.
According to a public notice issued on June 13, copies of the proposed budget were made available to the community for review starting May 23. Residents could request a copy from Guest Services Supervisor Melissa McGrath.
At the meeting, Board President Schulz called for any final questions or comments on the ordinance from the commissioners. Hearing none, he requested a motion for its approval. The motion was made by Commissioner Kraemer and seconded by Commissioner Fischer, passing with a unanimous voice vote.
The approved ordinance will guide the park district’s spending and financial operations from the start of the new fiscal year, funding everything from park maintenance and recreational programming to capital projects and staff salaries.
Latest News Stories
Cook County offers loans after latest tax bill delays
Illinois Quick Hits: Storms cause damage, closures
Extension of pension buyout program to drop $144B liability
Schools face bus funding, cost challenges
‘Family Month’ backer cites biology, declining birth rates in defense of resolution
Aldermen say lawmakers failed to address illegal cannabis sales near schools
Illinois Quick Hits: Oak Park woman charged with child care fraud
Florida attorney general appeals Chicago judge’s ‘lawless’ transgender ruling
Congressman calls out Chicago schools’ academic woes
Everyday Economics: A stable labor market is not enough
Fishermen advocate begins campaign against offshore wind, ‘industrializing’ of the ocean
Sorensen drug-pricing bill draws criticism from former FDA official